Merck Chooses Addex a Second Time |
Abstract
pdf
|
Business Review Editor |
|
Post Exubera#174;: Can New Life be Breathed Back into Inhaled Insulin? |
Abstract
pdf
|
Business Review Editor |
|
Therapy Focus: Prostate Cancer |
Abstract
pdf
|
Business Review Editor |
|
Human Genome Sciences Boosts Cancer Pipeline |
Abstract
pdf
|
Business Review Editor |
|
Pfizer and Tacere to Tackle HCV with RNAi Therapeutic |
Abstract
pdf
|
Business Review Editor |
|
Making Sense Out of Antisense |
Abstract
|
Business Review Editor |
|
Royal Philips Electronics to Acquire Respironics |
Abstract
pdf
|
Business Review Editor |
|
Roche’s Persistence in Face of Ventana’s Opposition Pays Off |
Abstract
pdf
|
Business Review Editor |
|